Margarite D. Matossian

911 total citations
39 papers, 588 citations indexed

About

Margarite D. Matossian is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Margarite D. Matossian has authored 39 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 18 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Margarite D. Matossian's work include Cancer Cells and Metastasis (18 papers), Estrogen and related hormone effects (7 papers) and HER2/EGFR in Cancer Research (6 papers). Margarite D. Matossian is often cited by papers focused on Cancer Cells and Metastasis (18 papers), Estrogen and related hormone effects (7 papers) and HER2/EGFR in Cancer Research (6 papers). Margarite D. Matossian collaborates with scholars based in United States, China and Italy. Margarite D. Matossian's co-authors include Matthew E. Burow, Bridgette M. Collins‐Burow, Lucio Miele, Bruce A. Bunnell, Silvana Papagerakis, Mark E. Prince, Li Zheng, Hope E. Burks, Rachel A. Sabol and Petros Papagerakis and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Margarite D. Matossian

36 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margarite D. Matossian United States	14	314	258	136	52	50	39	588
Amar Desai United States	11	386 1.2×	185 0.7×	157 1.2×	76 1.5×	52 1.0×	23	599
Erika Durinikova Slovakia	12	220 0.7×	206 0.8×	132 1.0×	33 0.6×	47 0.9×	17	477
Teresa Gagliano Italy	15	297 0.9×	200 0.8×	149 1.1×	39 0.8×	74 1.5×	36	615
Veronica Veschi Italy	16	444 1.4×	266 1.0×	181 1.3×	114 2.2×	49 1.0×	26	701
Ola Hadadeh Lebanon	12	342 1.1×	181 0.7×	182 1.3×	89 1.7×	94 1.9×	16	676
Carmen Ghilardi Italy	14	384 1.2×	243 0.9×	178 1.3×	61 1.2×	55 1.1×	23	635
Ki-Chun Yoo South Korea	14	291 0.9×	199 0.8×	153 1.1×	61 1.2×	55 1.1×	20	536
M. Victoria Recouvreux United States	11	363 1.2×	155 0.6×	202 1.5×	50 1.0×	34 0.7×	12	655
Johanna M. Buschhaus United States	11	319 1.0×	211 0.8×	182 1.3×	39 0.8×	40 0.8×	19	547
Yoshinari Shinsato Japan	14	284 0.9×	164 0.6×	129 0.9×	40 0.8×	72 1.4×	20	523

Countries citing papers authored by Margarite D. Matossian

Since Specialization

Citations

This map shows the geographic impact of Margarite D. Matossian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margarite D. Matossian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margarite D. Matossian more than expected).

Fields of papers citing papers by Margarite D. Matossian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margarite D. Matossian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margarite D. Matossian. The network helps show where Margarite D. Matossian may publish in the future.

Co-authorship network of co-authors of Margarite D. Matossian

This figure shows the co-authorship network connecting the top 25 collaborators of Margarite D. Matossian. A scholar is included among the top collaborators of Margarite D. Matossian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margarite D. Matossian. Margarite D. Matossian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matossian, Margarite D., Jorge A. Belgodere, Van T. Hoang, et al.. (2025). NEK Family Kinases: Structure, Function, and Role in Disease. Biomolecules. 15(10). 1406–1406.

Chen, Nan, Margarite D. Matossian, Murtuza Rampurwala, et al.. (2025). A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer. Breast Cancer Research and Treatment. 211(1). 111–119. 1 indexed citations

Sabol, Rachel A., et al.. (2024). Mechanical Disruption by Focused Ultrasound Re-sensitizes ER+ Breast Cancer Cells to Hormone Therapy. Ultrasound in Medicine & Biology. 50(12). 1885–1892. 1 indexed citations

Matossian, Margarite D., Nan Chen, & Rita Nanda. (2023). Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities. Current Breast Cancer Reports. 15(3). 266–278. 1 indexed citations

Chen, Nan, Murtuza Rampurwala, Sailaja Kamaraju, et al.. (2023). A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.. Journal of Clinical Oncology. 41(16_suppl). e13103–e13103. 3 indexed citations

Bunnell, Bruce A., Elizabeth C. Martin, Margarite D. Matossian, et al.. (2022). The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer. Cancer and Metastasis Reviews. 41(3). 549–573. 24 indexed citations

Cromwell, Evan F., Oksana Sirenko, Matthew A. Hammer, et al.. (2022). Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modeling. SLAS DISCOVERY. 27(3). 191–200. 9 indexed citations

Brown, Morgan L., Margarite D. Matossian, Stacey L. Holman, et al.. (2022). ERAS implementation in an urban patient population undergoing gynecologic surgery. Best Practice & Research Clinical Obstetrics & Gynaecology. 85(Pt B). 1–11. 8 indexed citations

Dong, Shengli, Hassan Yousefi, Samuel C. Okpechi, et al.. (2022). Ceritinib is a novel triple negative breast cancer therapeutic agent. Molecular Cancer. 21(1). 138–138. 22 indexed citations

10.

Matossian, Margarite D., Khoa Nguyen, Celia Byrne, et al.. (2022). Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer. Frontiers in Molecular Biosciences. 9. 847505–847505. 5 indexed citations

11.

Burks, Hope E., Margarite D. Matossian, Lyndsay V. Rhodes, et al.. (2021). ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism. Breast Cancer Research and Treatment. 189(1). 25–37. 10 indexed citations

12.

Matossian, Margarite D., Steven Elliott, Lyndsay V. Rhodes, et al.. (2021). Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant‑resistant phenotype in breast cancer cells. Oncology Letters. 21(5). 380–380.

13.

Matossian, Margarite D., Van T. Hoang, Hope E. Burks, et al.. (2021). Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer. Oncoscience. 8. 61–71. 2 indexed citations

14.

Matossian, Margarite D., Steven Elliott, Khoa Nguyen, et al.. (2020). Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer. Women s Health Reports. 1(1). 383–392. 6 indexed citations

15.

Wright, Thomas D., Margarite D. Matossian, Steven Elliott, et al.. (2019). Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs. Molecular Pharmacology. 96(2). 272–296. 32 indexed citations

16.

Guo, Shanchun, Changde Zhang, Melyssa R. Bratton, et al.. (2018). ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models. Oncotarget. 9(6). 6924–6937. 28 indexed citations

17.

Anbalagan, Muralidharan, Yifang Zhang, Yuanjun Gao, et al.. (2017). Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression. Molecular Cancer Research. 15(11). 1491–1502. 13 indexed citations

18.

Matossian, Margarite D., Steven Elliott, Van T. Hoang, et al.. (2017). Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes. PLoS ONE. 12(8). e0177802–e0177802. 4 indexed citations

19.

Papagerakis, Silvana, Giuseppe Pannone, Li Zheng, et al.. (2014). Oral epithelial stem cells—Implications in normal development and cancer metastasis. Experimental Cell Research. 325(2). 111–129. 40 indexed citations

20.

Divi, Vasu, Margarite D. Matossian, John H. Owen, et al.. (2014). Evaluation of CD44 Variant Expression in Oral, Head and Neck Squamous Cell Carcinomas Using a Triple Approach and its Clinical Significance. International Journal of Immunopathology and Pharmacology. 27(3). 337–349. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact